|

Beinaglutide Clinical Trials

1 actively recruiting trial

Top Sponsors

  • Beijing Hospital1

Indications

  • Type 2 Diabetic Patients1
  • T2DM (Type 2 Diabetes Mellitus)1
  • T2DM1
  • Diabetes1

Other1 trial

Comparing the Efficacy and Safety Between Continuous Subcutaneous Beinaglutide and CSII for Newly Diagnosed T2DM Patients
N/A

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.